Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results
Director departure
Appointed director

EAGLE PHARMACEUTICALS, INC. (EGRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 4 Tarriff Scott (CEO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Sold 9,511 shares @ $15.23, valued at $144.9k
Sold 10,024 shares @ $14.41, valued at $144.4k
Sold 710 shares @ $15.11, valued at $10.7k
05/18/2023 4 Tarriff Scott (CEO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Sold 15,000 shares @ $19.98, valued at $299.7k
05/15/2023 4 Tarriff Scott (CEO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Sold 15,000 shares @ $20.71, valued at $310.7k
Sold 3,131 shares @ $19.69, valued at $61.6k
Sold 11,869 shares @ $20.42, valued at $242.4k
Sold 14,800 shares @ $21.06, valued at $311.7k
Sold 200 shares @ $21.52, valued at $4.3k
03/09/2023 4 RATOFF STEVEN B (Director) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Granted 16,253 options to buy @ $26, valued at $422.6k
03/09/2023 4 Graves Michael (Director) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Granted 16,253 options to buy @ $26, valued at $422.6k
03/09/2023 4 Simpson Jennifer K. (Director) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Granted 16,253 options to buy @ $26, valued at $422.6k
03/09/2023 4 Glenning Robert (Director) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Granted 16,253 options to buy @ $26, valued at $422.6k
03/09/2023 4 Edlin Richard A. (Director) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Granted 16,253 options to buy @ $26, valued at $422.6k
03/09/2023 4 BORIO LUCIANA (Director) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Granted 16,253 options to buy @ $26, valued at $422.6k
03/02/2023 4 Cahill Brian Joseph (CFO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 718 shares @ $28, valued at $20.1k
Granted 18,500 shares @ $0
03/02/2023 4 Tarriff Scott (CEO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 3,113 shares @ $28, valued at $87.2k
Granted 70,900 shares @ $0
02/06/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/31/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/24/2023 4 Tarriff Scott (CEO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 3,732 shares @ $33.64, valued at $125.5k
01/09/2023 4 Cahill Brian Joseph (CFO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 734 shares @ $29.26, valued at $21.5k
01/09/2023 4 Tarriff Scott (CEO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 3,827 shares @ $29.26, valued at $112k
12/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/08/2022 4 Edlin Richard A. (Director) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Sold 6,800 shares @ $30.99, valued at $210.7k
03/02/2022 4 BORIO LUCIANA (Director) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Granted 11,200 options to buy @ $47.39, valued at $530.8k
03/02/2022 4 Moran Michael Shawn (EVP, Chief Commercial Officer) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Granted 10,400 shares @ $0
03/02/2022 4 Cahill Brian Joseph (CFO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Granted 8,000 shares @ $0
03/02/2022 4 Edlin Richard A. (Director) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Granted 11,200 options to buy @ $47.39, valued at $530.8k
03/02/2022 4 Simpson Jennifer K. (Director) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Granted 11,200 options to buy @ $47.39, valued at $530.8k
03/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2022 4 Graves Michael (Director) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Granted 11,200 options to buy @ $47.39, valued at $530.8k
03/02/2022 4 Glenning Robert (Director) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Granted 11,200 options to buy @ $47.39, valued at $530.8k
02/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/01/2022 4 Moran Michael Shawn (EVP, Chief Commercial Officer) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 210 shares @ $45.94, valued at $9.6k
02/01/2022 4 Cahill Brian Joseph (CFO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 626 shares @ $45.94, valued at $28.8k
01/11/2022 4 Moran Michael Shawn (EVP, Chief Commercial Officer) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 90 shares @ $50.63, valued at $4.6k
01/11/2022 4 Cahill Brian Joseph (CFO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 263 shares @ $50.63, valued at $13.3k
01/07/2022 4 Moran Michael Shawn (EVP, Chief Commercial Officer) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 1,511 shares @ $50.69, valued at $76.6k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy